Update on the COVID‐19‐associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome‐temporally associated with SARS‐CoV‐2

Field	Value	Language
dc.contributor.author	Singh-Grewal, Davinder	en
dc.contributor.author	Lucas, Ryan	en
dc.contributor.author	McCarthy, Kristine	en
dc.contributor.author	Cheng, Allen C	en
dc.contributor.author	Wood, Nicholas	en
dc.contributor.author	Ostring, Genevieve	en
dc.contributor.author	Britton, Philip	en
dc.contributor.author	Crawford, Nigel	en
dc.contributor.author	Burgner, David	en
dc.date.accessioned	2020-08-14
dc.date.available	2020-08-14
dc.date.issued	2020	en
dc.identifier.uri	https://hdl.handle.net/2123/23057
dc.description.abstract	We provide an update on the state of play with regards a newly described inflammatory condition which has arisen during the current SARS‐CoV‐2 pandemic. The condition has been named paediatric inflammatory multisystem syndrome temporally associated with SARS‐CoV‐2 or multisystem inflammatory syndrome in children. This condition has shown significant similarities to Kawasaki disease and toxic shock syndrome.	en
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	Update on the COVID‐19‐associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome‐temporally associated with SARS‐CoV‐2	en
dc.type	Article	en
dc.identifier.doi	10.1111/jpc.15049
usyd.faculty	Faculty of Medicine and Health, Sydney Medical School	en

Associated file/s

There are no files associated with this item.